CNR Institutional Research Information System

SPOTO, BELINDA GILDA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.903
NA - Nord America 841
EU - Europa 468
SA - Sud America 355
AF - Africa 39
OC - Oceania 5
Totale 3.611
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 837
US - Stati Uniti d'America 795
CN - Cina 406
BR - Brasile 278
VN - Vietnam 204
HK - Hong Kong 198
IT - Italia 174
FR - Francia 120
KR - Corea 69
BD - Bangladesh 48
IN - India 32
AR - Argentina 31
JP - Giappone 30
NL - Olanda 28
DE - Germania 25
GB - Regno Unito 24
CA - Canada 18
MX - Messico 17
FI - Finlandia 16
EC - Ecuador 13
ID - Indonesia 13
UA - Ucraina 13
IQ - Iraq 11
SA - Arabia Saudita 11
RU - Federazione Russa 10
UY - Uruguay 9
IL - Israele 8
PL - Polonia 8
AT - Austria 7
CO - Colombia 7
EG - Egitto 7
ES - Italia 7
IE - Irlanda 7
MA - Marocco 7
VE - Venezuela 7
SE - Svezia 6
TR - Turchia 6
AU - Australia 5
HR - Croazia 5
PK - Pakistan 5
JO - Giordania 4
OM - Oman 4
TN - Tunisia 4
ZA - Sudafrica 4
AL - Albania 3
CR - Costa Rica 3
DZ - Algeria 3
GR - Grecia 3
KE - Kenya 3
MY - Malesia 3
NP - Nepal 3
PE - Perù 3
PH - Filippine 3
TT - Trinidad e Tobago 3
BO - Bolivia 2
CI - Costa d'Avorio 2
CL - Cile 2
HU - Ungheria 2
JM - Giamaica 2
KZ - Kazakistan 2
LT - Lituania 2
NG - Nigeria 2
PT - Portogallo 2
PY - Paraguay 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BS - Bahamas 1
DK - Danimarca 1
ET - Etiopia 1
GF - Guiana Francese 1
MM - Myanmar 1
MR - Mauritania 1
MT - Malta 1
NI - Nicaragua 1
NO - Norvegia 1
RS - Serbia 1
RW - Ruanda 1
SI - Slovenia 1
SN - Senegal 1
SO - Somalia 1
TG - Togo 1
TW - Taiwan 1
ZW - Zimbabwe 1
Totale 3.611
Salva come PNG Salva come JPEG
Città #
Singapore 512
Santa Clara 249
Hong Kong 197
Hefei 116
Lauterbourg 101
Beijing 95
San Jose 86
Ashburn 80
Ho Chi Minh City 72
Los Angeles 68
Seoul 67
Hanoi 46
São Paulo 27
New York 26
Dallas 19
Tokyo 19
Frankfurt am Main 13
Helsinki 12
Rio de Janeiro 10
Amsterdam 9
Buffalo 9
Da Nang 9
Milan 9
Belo Horizonte 8
Düsseldorf 8
Haiphong 8
Minamishinagawa 8
Warsaw 8
Chennai 7
Orem 7
Brasília 6
Dublin 6
Montevideo 6
Rome 6
Stockholm 6
Thái Bình 6
Bari 5
Biên Hòa 5
Cairo 5
Catania 5
Guarulhos 5
Houston 5
Hải Dương 5
Osasco 5
Zagreb 5
Amman 4
Baghdad 4
Bengaluru 4
Buenos Aires 4
Curitiba 4
Denver 4
Guayaquil 4
Jeddah 4
Lappeenranta 4
Manchester 4
Naples 4
Paris 4
Paternò 4
Philadelphia 4
Quito 4
Riyadh 4
Sorocaba 4
Toronto 4
Vienna 4
Belém 3
Brooklyn 3
Bắc Giang 3
Can Tho 3
Catalão 3
Chicago 3
City of London 3
Council Bluffs 3
Florence 3
Formosa 3
Ha Long 3
Hyderabad 3
Jakarta 3
London 3
Mosul 3
Nairobi 3
New Delhi 3
Newark 3
Phoenix 3
Portsmouth 3
Quảng Ngãi 3
Seeb 3
Sydney 3
Turin 3
Vitória de Santo Antão 3
Vĩnh Long 3
Abidjan 2
Aci Catena 2
Aracaju 2
Athens 2
Atlanta 2
Avellaneda 2
Bandung 2
Barretos 2
Basra 2
Belo Jardim 2
Totale 2.160
Salva come PNG Salva come JPEG
Nome #
8-hydroxy-2′-deoxyguanosine, a biomarker of oxidative DNA injury, in diabetic kidney disease 117
Role of Gut Microbiota in Overweight Susceptibility in an Adult Population in Italy 117
Neuropeptide y gene polymorphisms and chronic kidney disease progression 74
Role of kidney function on Nrf2 mRNA levels in type 2 diabetes 70
Joint effect of insulin signaling genes on cardiovascular events and on whole body and endothelial insulin resistance 68
Sample Size Calculation in Genetic Association Studies: A Practical Approach 68
Selenoprotein P-1 (SEPP1) as an Early Biomarker of Acute Kidney Injury in Patients Undergoing Cardiopulmonary Bypass 67
ACE genotype and ACE inhibitors induced renoprotection in chronic proteinuric nephropathies 66
A polymorphism in the major gene regulating serum uric acid associates with clinic SBP and the white-coat effect in a family-based study 66
Serum gamma-glutamyltransferase, oxidized LDL and mortality in the elderly 64
Elementi di fisiologia e biologia molecolare del trasporto tubulare del sodio 62
Inflammation biomarkers and inflammatory genes expression in metabolically healthy obese patients 61
Hyperhomocysteinemia and arteriovenous fistula thrombosis in hemodialysis patients 60
Perioperative Marinobufagenin (MBG) Measurement May Improve Acute Kidney Injury Risk Assessment in Patients Undergoing Major Cardiac Surgery: A Proof-of-Concept Study 57
Selenoprotein P-1 (SEPP1) as an Early Biomarker of Myocardial Injury in Patients Undergoing Cardiopulmonary Bypass 57
A Genetic Marker of Uric Acid Level, Carotid Atherosclerosis, and Arterial Stiffness: A Family-Based Study 55
The sirtuinl gene associates with left ventricular myocardial hypertrophy and remodeling in two chronic kidney disease cohorts: a longitudinal study 55
Neuropeptide Y as a risk factor for cardiorenal disease and cognitive dysfunction in chronic kidney disease: translational opportunities and challenges 52
Pro- and anti-inflammatory cytokine gene expression in subcutaneous and visceral fat in severe obesity 51
Association of IL-6 and a functional polymorphism in the IL-6 gene with cardiovascular events in patients with CKD 50
Synergism between asymmetric dimethylarginine (ADMA) and a genetic marker of uric acid in CKD progression 48
Tissue inhibitor of metalloproteinases (TIMP-1), genetic markers of insulin resistance and cardiomyopathy in patients with kidney failure 48
Serum Erythroferrone Levels Associate with Mortality and Cardiovascular Events in Hemodialysis and in CKD Patients: A Two Cohorts Study 47
A polymorphismin a major antioxidant gene (Kelch-like ECH-associated protein1) predicts incident cardiovascular events in chronic kidney disease patients: an exploratory study 47
A POLYMORPHISM IN THE SIRT-1 GENE ASSOCIATES WITH CONCENTRIC REMODELLING OF THE LEFT VENTRICLE AND PREDICTS THE LONGITUDINAL EVOLUTION OF THIS ALTERATION BOTH IN STAGE G1-5 CKD PATIENTS AND IN DIALYSIS PATIENTS 46
Neuropeptide Y receptor Y2 gene polymorphism interacts with plasma neuropeptide Y levels in predicting left ventricular hypertrophy in dialysis patients 42
Mendelian randomization: a new approach to studying epidemiology in ESRD 42
Joint effect of insulin signaling genes on cardiovascular events and on whole body and endothelial insulin resistance. 41
Atherosclerosis and the Glu298Asp polymorphism of the eNOS gene in white patients with end stage renal disease. 41
A Genetic Biomarker of Oxidative Stress, the Paraoxonase-1 Q192R Gene Variant, Associates with Cardiomyopathy in CKD: A Longitudinal Study 40
Plasma cytokines, glomerular filtration rate and adipose tissue cytokines gene expression in chronic kidney disease (CKD) patients. 40
The rs17384213 polymorphism in the DDAH1 gene is a marker of chronic allograft dysfunction. 39
eNOS and Caveolin-1 Gene Polymorphisms Interaction and Intima Media Thickness: A Proof of Concept Study in ESRD Patients. 39
Resistin and all-cause and cardiovascular mortality: Effect modification by adiponectin in end-stage kidney disease patients 39
Insulin resistance in chronic kidney disease: a systematic review 39
Association of a polymorphism in a gene encoding a urate transporter with ckd progression 37
The ENPP1 Q121 variant predicts major cardiovascular events in high-risk individuals: Evidence for interaction with obesity in diabetic patients 37
I polimorfismi del gene ENPP1 si associano ad ipertrofia ventricolare sinistra ed alla funzione sistolica nei pazienti in dialisi. 37
Circulating adiponectin modifies the FGF23 response to vitamin D receptor activation: a post hoc analysis of a double-blind, randomized clinical trial 36
Polymorphismes des gènes du système rènine et progression de l'atteinte rènale : une revue critique 35
The E-selectin gene polymorphism and carotid atherosclerosis in end-stage renal disease. 34
La randomizzazione Mendaliana come "variabile strumentale" negli studi osservazionali. 34
An additive effect of endothelial nitric oxide synthase gene polymorphism contributes to the severity of atherosclerosis in patients on dialysis. 34
Il sistema metabolico che regola l'ADMA è presente negli adipociti umani ed è iperespresso nell'insufficienza renale. 33
The fat-mass and obesity-associated gene (FTO) predicts mortality in chronic kidney disease of various severity 33
Joint effect of insulin signaling genes on all-cause mortality 33
Il polimorfismo T585C del gene del recettore Y2 del Neuropeptide Y (NPY2R) interagisce con i livelli plasmatici di NPY nel predire l'ipertrofia ventricolare sinistra (IVS) nei pazienti in dialisi. 32
Oxidized LDL, Gamma-Glutamyltransferase and Adverse Outcomes in Older Adults 32
ENPP1 Gene Polymorphisms are associated with left ventricular (LV) mass and systolic function in end stage renal disease (ESRD) patients. 31
Functional correlates and gene expression in fat cells of visfatin/pre-b cell enhancing factor in ckd patients. 30
The deletion polymorphism of the angiotensin-converting-enzyme is associated with nephroangiosclerosis 29
Vitamin D receptor activation by paricalcitol and insulin resistance in CKD 29
Endothelial nitric oxide sinthase (eNOS) polymorphism interacts with asimmetric dimethyl arginine (ADMA) in determining all cause and cardiovascular mortality in patients with ESRD. 28
Infiammazione sistemica ed espressione genica nel tessuto adiposo sottocutaneo delle citochine infiammatorie nei pazienti con insufficienza renale cronica. 28
Interazione tra le varianti geniche della Caveolina-1 e dell'ossido nitrico sintetasi nel determinare la severità dell'aterosclerosi carotidea nei pazienti in dialisi. 28
Insulin resistance and left ventricular hypertrophy in end-stage renal disease: association between the ENPP1 gene and left ventricular concentric remodelling. 28
The enzymatic machinery for ADMA synthesis and degradation is fully expressed in human adipocytes 27
Il sistema metabolico che regola l'ADMA è presente negli adipociti umani ed è iperespresso nell'insufficienza renale. 27
Association between resistin levels and all-cause and cardiovascular mortality: A new study and a systematic review and meta-analysis 27
ACE-genotype and ACE-inhibitors-induced renoprotection in chronic proteinuric nephrophaties 27
Does asymmetric dimethylarginine play a role in depression in chronic kidney disease patients? 26
Interazioni tra le varianti geniche dell'ossido nitrico sintetasi e l'ADMA plasmatica nella mortalità cardiovascolare nei pazienti in dialisi 26
Joint effect of insulin signaling genes on cardiovascular events and on whole body and endothelial insulin resistance 26
Methodology used in studies reporting chronic kidney disease prevalence: a systematic literature review 26
Tissue inhibitor of metalloproteinases (TIMP-1), genetic markers of insulin resistance and cardiomyopathy in patients with kidney failure. 26
Urotension II and renal disease: protective or causal role? 26
Valore prognostico della variante Glu298Asp dell'ossido nitrico sintetasi (eNOS) e dell'interazione eNOS-Arginina Asimmetrica (ADMA) nei pazienti in dialisi. 25
Polymorphisms in the genes of the renin system and progression of renal disease: a critical review 25
The GLU298ASP variant of nitric oxide synthase interacts with asymmetric dimethyl arginine in determining cardiovascular mortality in patients with end-stage renal disease 25
Proteinuria: a risk factor not to be overlooked in SLE 24
Le componenti funzionali che controllano la sintesi e la degradazione della dimetil-arginina asimmetrica (ADMA) sono espresse nel tessuto adiposo. 24
Genetica dell'iperaldosteronismo primitivo. 24
Asymmetric Dimethylarginine (ADMA) Enzymatic Machinery and Adipokines Gene Expression in the Adipose Tissue in Stage 3-5 CKD patients. 24
The full ADMA machinery is expressed in human adipocytes: differential regulation in healthy and uremic man. 24
ADMA machinery is expressed in adipocytes in humans and it is differentially regulated in CKD and ESRD patients 24
Adipose tissue cytokines, insulin sensitivity, inflammation, and cardiovascular outcome stage renal disease patients. 23
Insulin Sensitivity, Systemic Inflammation and Adipose Tissue Gene Expression of Inflammatory Cytokines in Chronic Kidney Disease (CKD) and in Obese Patients. 23
Resistin and all-cause and cardiovascular mortality: effect modification by adiponectin in end-stage kidney disease patients. 23
The full ADMA machinery is expressed in human adipocytes: differential regulation in healthy and uremic man. 23
Methodology used in studies reporting chronic kidney disease prevalence: a systematic literature review (vol 30, pg 6, 2015) 22
Insulin Sensitivity, Systemic Inflammation and Adipose Tissue Gene Expression of Inflammatory Cytokines in Chronic Kidney Disease (CKD) and in Obese Patients. 22
Il polimorfismo T585C del gene del ricettore Y2 del neuropeptide Y (NPY2R) interagisce con i livelli plasmatici di NPY nel determinismo dell'ipertrofia ventricolare sinistra (IVS) nei pazienti in dialisi. 22
I polimorfismi del gene che regola la sintetasi dell'ossido nitrico contribuiscono all'aterosclerosi nei pazienti in dialisi. 22
Functional correlates and gene expression in fat cells of visfatin/pre-b cell enhancing factor in CKD patients. 22
Il polimorfismo C242T del gene per la subunità p22 dell'NADPH e il rischio cardiovascolare nei pazienti in dialisi. 21
L'allele T della variante GLU298ASP dell'ossido nitrico sintetasi (eNOS) è un fattore predittivo indipendente di aterosclerosi carotidea nei pazienti in dialisi. 21
Polymorphisms in the genes of the renin system and progression of renal disease: a critical review. 20
Estimated Glomerular Filtration Rate, All-Cause Mortality and Cardiovascular Diseases Incidence in a Low Risk Population: The MATISS Study 20
Systemic and adipose tissue inflammation in chronic kidney disease (CKD) patients. 20
Methylarginine enzymatic machinery and Leptin in adipose tissue in CKD patients. 20
The interaction of a common variant of the eNOS gene with asymmetric dimethylarginine (ADMA) in carotid atherosclerosis in end stage renal disease (ESRD). 20
MicroRNA: una piccola grande molecola. 20
Effect of simvastatin on plasma asymmetric dimethylarginine concentration in patients with chronic kidney disease. 20
Polymorphisms within the endpthelial nitric oxide synthase gene interact with plasma ADMA in predicting cardiovascular mortality in ESRD patients 20
Adpose tissue and renal disease. 20
Spleen IL-10, a key player in obesity-driven renal risk 19
The deletion polymorphism of the angiotensin-converting enzyme is associated with nephroangiosclerosis. 19
Methylarginine enzymatic machinery and Leptin in adipose tissue in CKD patients. 18
eNOS gene polymorphisms contribute to the severity of carotid atherosclerosis in dialysis patients. 18
BRAIN NATRIURETIC PEPTIDE AS A BIOMARKER OF PULMONARY CONGESTION IN STAGE 5 CKD ON DIALYSIS 18
Totale 3.652
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.334
article - articoli 9.951
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 222
Totale 23.507
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202461 0 0 0 0 0 0 0 0 40 0 21 0
2024/20251.438 12 5 127 104 288 17 29 84 75 53 358 286
2025/20262.245 107 223 196 291 406 111 375 144 100 137 104 51
Totale 3.744